to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
One thing that helps entrepreneurs is networking. So every week @emedcommunity is going to highlight some healthcare and life science entrepreneurs on twitter you should consider following. This is not an endorsement, but an encouragement. Network with your peers!
The term “access” can have a variety of definitions for life science and digital health entrepreneurs, depending on the phase of their company’s development. Similarly, the ability for entrepreneurs to secure access – whether to potential buyers or to funding – varies depending on the type of access they’re seeking and the stage of their company.
See who we're following this week for insights of importance to healthcare entrepreneurs.
Find out who we are highlighting in this week's eMed's 6 entrepreneurs to follow on twitter.
Join the conversation this week with eMed's entrepreneurs to follow on twitter.
The team at Ginger.io, a Cambridge, Mass.-based health data company, had a great product: a behavior analytics platform using smartphone data to create health insights. But they needed a clinical partner to help get access to patients and physicians. That’s where C3N came in.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
Dr. Todd O’Brien has additional challenges beyond those encountered by most startup life science CEOs. The 48-year-old podiatrist still sees patients even while developing his latest innovation: an electronic tuning fork for measuring diabetes-related nerve damage in people’s feet. He's also building his company in Orono, Maine - far from any major healthcare hub.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.